Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
Huang, Y., Ren, J., & Qu, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00672 · Cited by 3,523
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
“It is characterized by accumulations of b-amyloid plaques and neurofibrillary tangles [2–6], which exert direct and indirect neurotoxic effects by promoting oxidative stress [7,8] and inflammation.”
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
“While he pathway of the neurofibrillary tangles is very precise, ie, tarts in the entorhinal cortex from where it progresses to he hippocampus, the limbic system, and finally to neocorical regions, the amyloid deposition seems to be more eterogeneous and random starting first in neocortical reions before it affects al…”
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Glymphatic failure as a final common pathway to dementia
Nedergaard, M., & Goldman, S. A. (2020) · Science · doi:10.1126/science.abb8739 · Cited by 1,145
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Mistranslation-Induced Protein Misfolding as a Dominant Constraint on Coding-Sequence Evolution
Drummond, D. A., & Wilke, C. O. (2008) · Cell · doi:10.1016/j.cell.2008.05.042 · Cited by 1,053
“Neurodegenerative diseases disproportionately involve protein misfolding and aggregation (Soto, 2003).”
ER stress and the unfolded protein response in neurodegeneration
Hetz, C., & Saxena, S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.99 · Cited by 1,013
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Principles of protein folding, misfolding and aggregation
Dobson, C. M. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.008 · Cited by 904
“5, and many show considerable promise [86,99–103].”
Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
Ciechanover, A., & Kwon, Y. T. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.117 · Cited by 898
ER stress and neurodegenerative diseases
Lindholm, D., Wootz, H., & Korhonen, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401778 · Cited by 882
“It is generally thought that the activity of UPS is mitigated in these diseases either by the protein aggregates or by enhanced oxidative stress and other toxic products.(7,8) Dysfunctional UPS in turn cause more accumula-”
BackgroundReview: microglia of the aged brain: primed to be activated and resistant to regulation
Norden, D. M., & Godbout, J. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01306.x · Cited by 792
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
Valentine, J. S., Doucette, P. A., & Zittin Potter, S. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161647 · Cited by 785
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
“…and other chronic neurodegenerative conditions in that they are typified by the extracellular deposition of insoluble plaques, show neurodegeneration along neuroanatomical pathways , and display marked astrocytosis and microglial activation (DeArmond, 1993; Price et al., 1993; Soto et al., 2003).”
BackgroundDisturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684
Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., & Baldus, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506109102 · Cited by 647
Widespread protein aggregation as an inherent part of aging in C. elegans
David, D. C., Ollikainen, N., Trinidad, J. C., Cary, M. P., Burlingame, A. L., & Kenyon, C. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000450 · Cited by 627
“In disease models for aberrant protein aggregation, protein aggregation is characterized by the assembly of the misfolded protein into microscopically visible aggregates [36].”
BackgroundRasmussen, M. K., Mestre, H., & Nedergaard, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00031.2020 · Cited by 597
Amyloid oligomers: formation and toxicity of Aβ oligomers
Sakono, M., & Zako, T. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07568.x · Cited by 605
“54 Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases.”
BackgroundPawar, A. P., DuBay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M., & Dobson, C. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.016 · Cited by 588
“It is important to identify such regions, as they may represent very favourable targets for therapeutic strategies based on their shielding, for example through competitive binding.(97,98) We define the second type of sensitive regions as aggregation-susceptible, or S regions in which large changes in the propensities…”
BackgroundMisfolded CuZnSOD and amyotrophic lateral sclerosis
Valentine, J. S., & Hart, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730423100 · Cited by 546
Shahnawaz, M., Tokuda, T., Waragai, M., Mendez, N., Ishii, R., Trenkwalder, C., Mollenhauer, B., & Soto, C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4547 · Cited by 489
Self-citationPrion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells
Münch, C., O’Brien, J., & Bertolotti, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017275108 · Cited by 479
“I many neurodegenerative diseases, such as Alzheimer’s disease, Parkinson disease, prion disorders, ALS, and polyglutamine (polyQ) expansion disorder, a specific protein converts from an otherwise soluble and benign conformation into a misfolded one that assembles into an amyloid or amyloid-like state, defined by a co…”
BackgroundSmall Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461
Sgourakis, N. G., Yan, Y., McCallum, S. A., Wang, C., & Garcia, A. E. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.093 · Cited by 457
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms
De, S., Wirthensohn, D. C., Flagmeier, P., Hughes, C., Aprile, F. A., Ruggeri, F. S., Whiten, D. R., Emin, D., Xia, Z., Varela, J. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09477-3 · Cited by 448
de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J. M., Drukarch, B., Hoozemans, J., & van Horssen, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.001 · Cited by 428
Design and Application of Fluorescent Probes to Detect Cellular Physical Microenvironments
Ma, J., Sun, R., Xia, K., Xia, Q., Liu, Y., & Zhang, X. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00573 · Cited by 408
Nollen, E. A. A., Garcia, S. M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R. I., & Plasterk, R. H. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307697101 · Cited by 416
Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Chi, H., Chang, H.-Y., & Sang, T.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103082 · Cited by 412
A review of the mammalian unfolded protein response
Chakrabarti, A., Chen, A. W., & Varner, J. D. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23282 · Cited by 409
“Several neurodegenerative diseases like Parkinson's disease, Alzheimer's disease; have been implicated to have accumulation of misfolded proteins leading to altered neuronal connectivity, neuronal death and and dysfunctional ERAD machinery (Soto, 2003; Bence et al., 2001; Katayama et al,. 1999) (Table 1).”
BackgroundEndoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases
Ghemrawi, R., & Khair, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176127 · Cited by 398
“Misfolded proteins may lose their physiological activity, acquire neurotoxicity and lead to chronic brain inflammation [19].”
BackgroundGaucher disease: complexity in a “simple” disorder
Sidransky, E. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.015 · Cited by 399
“[76] C.”
BackgroundEnzyme nanoarchitectonics: organization and device application
Ariga, K., Ji, Q., Mori, T., Naito, M., Yamauchi, Y., Abe, H., & Hill, J. P. (2013) · Chemical Society Reviews · doi:10.1039/c2cs35475f · Cited by 397
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein
Hetz, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg537 · Cited by 396
Self-citationOxidative Stress in Neurodegenerative Diseases
(2013) · Metal‐based Neurodegeneration · doi:10.1002/9781118553480.ch04 · Cited by 371
Huntington's disease: underlying molecular mechanisms and emerging concepts
Labbadia, J., & Morimoto, R. I. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.003 · Cited by 369
Höhn, A., Weber, D., Jung, T., Ott, C., Hugo, M., Kochlik, B., Kehm, R., König, J., Grune, T., & Castro, J. P. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.001 · Cited by 366
“Furthermore, age-related neurological disorders, such as Alzheimer's (AD) and Parkinson's Disease (PD), are mostly characterized by the accumulation of insoluble protein aggregates [113].”
BackgroundRNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila
Jin, P., Zarnescu, D. C., Zhang, F., Pearson, C. E., Lucchesi, J. C., Moses, K., & Warren, S. T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00533-6 · Cited by 360
Misfolded proteins in Alzheimer's disease and type II diabetes
DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15112f · Cited by 361
The role of FUS gene variants in neurodegenerative diseases
Deng, H., Gao, K., & Jankovic, J. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.78 · Cited by 366
“Normal FUS is a primarily nuclear, RNA-binding protein (1).”
BackgroundProtein Misfolding and Neurodegeneration
Soto, C., & Estrada, L. D. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.56 · Cited by 352
“Several mechanisms have been proposed for the neurotoxic activity of misfolded aggregates, and it is likely that different pathways operate depending on whether the proteins accumulate intracellularly or extracellularly.(1) Extracellular aggregates might activate a signal transduction pathway leading to apoptosis by i…”
BackgroundInfluentialSelf-citationFinder, V. H., & Glockshuber, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000100355 · Cited by 348
Liquid-liquid phase separation in biology: mechanisms, physiological functions and human diseases
Zhang, H., Ji, X., Li, P., Liu, C., Lou, J., Wang, Z., Wen, W., Xiao, Y., Zhang, M., & Zhu, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1702-x · Cited by 351
“Small oligomer forms of misfolded proteins or other states of protein aggregates such as amyloid-like fibrils cause cytotoxicity (Aguzzi and O’Connor, 2010; Soto, 2003; Stefani and Dobson, 2003).”
BackgroundType 2 diabetes as a protein misfolding disease
Mukherjee, A., Morales-Scheihing, D., Butler, P. C., & Soto, C. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.04.005 · Cited by 342
Self-citationDynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
Michaels, T. C. T., Šarić, A., Curk, S., Bernfur, K., Arosio, P., Meisl, G., Dear, A. J., Cohen, S. I. A., Dobson, C. M., Vendruscolo, M., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0452-1 · Cited by 339
“Over 50 such medical conditions have been identified, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis, that are associated with the misfolding and subsequent aggregation of proteins into amyloid fibrils and plaques [2–5].”
Structural Organization of α-Synuclein Fibrils Studied by Site-directed Spin Labeling
Der-Sarkissian, A., Jao, C. C., Chen, J., & Langen, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305266200 · Cited by 329
Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders
Doyle, K. M., Kennedy, D., Gorman, A. M., Gupta, S., Healy, S. J. M., & Samali, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01374.x · Cited by 321
“Significantly, the accumulation of misfolded proteins is a characteristic occurrence in many neurodegenerative diseases [3, 54, 55] and neurodegenerative diseases are often described as protein conformational disorders or proteinopathies [1].”
BackgroundRole of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313
“While spreading is involved in the progression of the disease among functionally connected brain areas, the transition from oligomers to insoluble deposits has been described as a “nucleation-dependent protein polymerization” and explains the pattern of aggregate formation [183] for proteins with high tendency to orga…”
BackgroundTam, S., Geller, R., Spiess, C., & Frydman, J. (2006) · Nature Cell Biology · doi:10.1038/ncb1477 · Cited by 309
“dtd" [ ]> Late-onset neurodegenerative diseases are often associated with the accumulation of insoluble amyloid aggregates in neuron”
Molecular Mechanisms and Potential Clinical Significance of S -Glutathionylation
Dalle–Donne, I., Milzani, A., Gagliano, N., Colombo, R., Giustarini, D., & Rossi, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1716 · Cited by 297
“…loss of function and may lead to either the unfolding and degradation of the damaged proteins by the proteasomal system, or to their progressive accumulation into cytoplasmic inclusions or extracellular aggregates, as observed in most age-related neurodegenerative disorders (16, 53, 153, 244).”
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
Perni, M., Galvagnion, C., Maltsev, A., Meisl, G., Müller, M. B. D., Challa, P. K., Kirkegaard, J. B., Flagmeier, P., Cohen, S. I. A., Cascella, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610586114 · Cited by 298
“Proc Natl Acad Sci USA 108(38):15978–15983.”
MethodA critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
Walsh, D. M., & Selkoe, D. J. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.13 · Cited by 294
Prion-like disorders: blurring the divide between transmissibility and infectivity
Cushman, M., Johnson, B. S., King, O. D., Gitler, A. D., & Shorter, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.051672 · Cited by 289
“Curiously, neither these diseases nor the amyloid forms involved are generally considered infectious (Forman et al., 2004; Soto, 2003).”
BackgroundPharmacological chaperones: potential treatment for conformational diseases
Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 283
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates
Soto, C., Estrada, L., & Castilla, J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.01.002 · Cited by 266
Self-citationLipid Membranes Modulate the Structure of Islet Amyloid Polypeptide
Jayasinghe, S. A., & Langen, R. (2005) · Biochemistry · doi:10.1021/bi050840w · Cited by 262
Modifiable Risk Factors for Alzheimer’s Disease
Edwards III, G. A., Gamez, N., Escobedo Jr., G., Calderon, O., & Moreno-Gonzalez, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00146 · Cited by 253
“Both AD and T2D are diseases related to protein misfolding and aggregation (Soto, 2003; Moreno-Gonzalez and Soto, 2011; Morales et al., 2013).”
BackgroundMisfolded protein aggregates: Mechanisms, structures and potential for disease transmission
Moreno-Gonzalez, I., & Soto, C. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.04.002 · Cited by 252
“This conformation is stabilized by intermolecular interactions, leading to the formation of oligomers, proto-fibrils and fibrils, which then accumulate as amyloid deposits in affected tissues [1,2].”
BackgroundSelf-citationJouanne, M., Rault, S., & Voisin-Chiret, A.-S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.070 · Cited by 252
Different Brain Regions are Infected with Fungi in Alzheimer’s Disease
Pisa, D., Alonso, R., Rábano, A., Rodal, I., & Carrasco, L. (2015) · Scientific Reports · doi:10.1038/srep15015 · Cited by 248
Xu, P.-X., Wang, S.-W., Yu, X.-L., Su, Y.-J., Wang, T., Zhou, W.-W., Zhang, H., Wang, Y.-J., & Liu, R.-T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.002 · Cited by 232
Gamma oscillations in cognitive disorders
Mably, A. J., & Colgin, L. L. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.07.009 · Cited by 244
Tam, S., Spiess, C., Auyeung, W., Joachimiak, L., Chen, B., Poirier, M. A., & Frydman, J. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1700 · Cited by 245
“1700" language="eng" relation="no"> Expansion of polyglutamine (polyQ) repeats beyond a critical threshold has been linked to protein toxicity in a number of neurodegenerative disorders, including Huntington's diseas”
Yan, L.-M., Tatarek-Nossol, M., Velkova, A., Kazantzis, A., & Kapurniotu, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507471103 · Cited by 244
Pathophysiological Roles of ASK1-MAP Kinase Signaling Pathways
Nagai, H., Noguchi, T., Takeda, K., & Ichijo, H. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.1.001 · Cited by 241
“…(HD), spinobulbar muscular atrophy (SBMA), and several forms of spinocerebellar ataxia (SCA) including SCA3/MachadoJoseph disease (MJD), are inherited neurodegenerative disorders induced by the insoluble aggregations of pathogenic proteins with expanded polyQ repeats (Kakizuka, 1998; Soto, 2003).”
BackgroundProtein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus
Ashraf, G., Greig, N., Khan, T., Hassan, I., Tabrez, S., Shakil, S., Sheikh, I., Zaidi, S., Akram, M., Jabir, N., et al. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917095514 · Cited by 236
“Hence there appears to be key regions within the structure of Aβ that favor the adoption of β-strand generation, residues 12 to 24 as well as 30 to 40, with the presence of a turn occuring primarily between these two regions, residues 25 to 30 [15, 50, 93, 94].”
BackgroundInfluentialNeuronal cell death mechanisms in Alzheimer’s disease: An insight
Goel, P., Chakrabarti, S., Goel, K., Bhutani, K., Chopra, T., & Bali, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.937133 · Cited by 234
“Most of neurodegenerative diseases are linked with formation/accumulation of pathological protein(s) to the extent of formation of high-order aggregates (Soto, 2003; Blokhuis et al., 2013; Michel et al., 2016).”
BackgroundIntrinsic disorder in proteins associated with neurodegenerative diseases
Uversky, V. (2009) · Frontiers in Bioscience · doi:10.2741/3594 · Cited by 233
“deterioration, are directly correlated with the length of the polyQ segment in ataxin1, a nuclear protein of ∼800 residues [257–259].”
BackgroundInvestigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling
Chen, M., Margittai, M., Chen, J., & Langen, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700368200 · Cited by 233
Infectious Agents and Neurodegeneration
De Chiara, G., Marcocci, M. E., Sgarbanti, R., Civitelli, L., Ripoli, C., Piacentini, R., Garaci, E., Grassi, C., & Palamara, A. T. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8320-7 · Cited by 228
“Although the distribution and composition of these protein aggregates are different in each neurodegenerative disease, they show similar morphological, structural and staining characteristics [89] and represent typical disease hallmarks.”
BackgroundEmerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease
Gerakis, Y., & Hetz, C. (2018) · The FEBS Journal · doi:10.1111/febs.14332 · Cited by 226
“123 Hetz C, Lee A-H, Gonzalez-Romero D, Thielen P, Castilla J, Soto C & Glimcher LH (2008) Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis.”
BackgroundInfluentialJNK Signalling: A Possible Target to Prevent Neurodegeneration
Borsello, T., & Forloni, G. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780858384 · Cited by 225
Endoplasmic reticulum stress compromises the ubiquitin–proteasome system
Menéndez-Benito, V., Verhoef, L. G. G. C., Masucci, M. G., & Dantuma, N. P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi312 · Cited by 222
“A common denominator in these diseases is the presence of proteins that undergo a conformational change from a soluble to a misfolded, aggregationprone structure, which eventually leads to the formation of the characteristic nuclear or cytosolic protein inclusions (2).”
BackgroundTau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220
“Proteolytic cleavage of specific proteins is the common denominator of many neurodegenerative diseases including huntingtin protein in Huntington’s disease [386,387], α-synuclein in Parkinson’s disease and Lewy body dementia [388], ataxins in cerebral ataxia [389,390], prion protein in prionosis [391,392] and tau”
BackgroundMorales, R., Moreno-Gonzalez, I., & Soto, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003537 · Cited by 218
“Disease-associated misfolded proteins usually organize in bsheet conformations that tend to form large aggregates and accumulate in different organs in the form of amyloid deposits, becoming toxic and leading to diverse protein misfolding diseases (PMDs), such as Alzheimer’s disease (AD), transmissible spongiform ence…”
BackgroundSelf-citationFirefly luciferase mutants as sensors of proteome stress
Gupta, R., Kasturi, P., Bracher, A., Loew, C., Zheng, M., Villella, A., Garza, D., Hartl, F. U., & Raychaudhuri, S. (2011) · Nature Methods · doi:10.1038/nmeth.1697 · Cited by 219
Protein aggregation and degradation mechanisms in neurodegenerative diseases.
Takalo, M., Salminen, A., Soininen, H. S., Hiltunen, M. O., & Haapasalo, A. (2013) · Europe PMC (PubMed Central) · Cited by 283
Sgourakis, N. G., Merced-Serrano, M., Boutsidis, C., Drineas, P., Du, Z., Wang, C., & Garcia, A. E. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.015 · Cited by 219
“The amyloid-β (Aβ) peptides are the major constituents of amyloid plaques, the pathological hallmark of Alzheimer's disease (AD) and neurodegeneration in general.(1) Aggregation of Aβ leads to various β-sheet-rich conformers that are found in the brains of AD patients and correlate with the onset of AD.”
BackgroundDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
Perez-Lloret, S., & Barrantes, F. J. (2016) · npj Parkinson's Disease · doi:10.1038/npjparkd.2016.1 · Cited by 210
“These cellular pathologies are closely intertwined with one of the hallmarks of the disease, namely the abnormal accumulation of misfolded protein aggregates.(5) Lewy bodies constitute a characteristic pathological finding, second only to the neurofibrillary tangles in Alzheimer's disease (AD).”
BackgroundLipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
Gobbi, M., Re, F., Canovi, M., Beeg, M., Gregori, M., Sesana, S., Sonnino, S., Brogioli, D., Musicanti, C., Gasco, P., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.044 · Cited by 192
Moreno-Gonzalez, I., Edwards III, G., Salvadores, N., Shahnawaz, M., Diaz-Espinoza, R., & Soto, C. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.230 · Cited by 209
“Soto@uth.tmc.edu (2)These authors contributed equally to this work. (3)Current address: Center for Integrative Biology, Universidad Mayor, Santiago, Chile. Received 18 May 2016; revised 29 September 2016; accepted 14 October 2016; published online 3 January 2017 Molecular Psychiatry (2017) 22, 1327–1334 © 2017 Macmill…”
Self-citationTransmissible Proteins: Expanding the Prion Heresy
Soto, C. (2012) · Cell · doi:10.1016/j.cell.2012.05.007 · Cited by 212
“Misfolded protein aggregates are implicated in more than 20 human diseases, collectively called protein misfolding disorders (PMDs), including highly prevalent and insidious illnesses such as Alzheimer’s disease, Parkinson’s disease, and type 2 diabetes (Soto, 2003; Chiti and Dobson, 2006).”
Self-citationExosomes in developmental signalling
McGough, I. J., & Vincent, J.-P. (2016) · Development · doi:10.1242/dev.126516 · Cited by 208
“Indeed, plaque-forming proteins that have been linked tomany neurodegenerative diseases (Soto, 2003), such as Parkinson’s, Alzheimer’s and amyotrophic lateral sclerosis, can be transferred from diseased to healthy cells on exosomes (Coleman and Hill, 2015; Emmanouilidou et al., 2010; Feiler et al.,…”
BackgroundEndoplasmic reticulum proteostasis impairment in aging
Martínez, G., Duran‐Aniotz, C., Cabral‐Miranda, F., Vivar, J. P., & Hetz, C. (2017) · Aging Cell · doi:10.1111/acel.12599 · Cited by 210
“(HD), prion-related disorders (PrDs), among others (Soto, 2003).”
BackgroundLuibl, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25843 · Cited by 203
“Among the principal differences is the fact that classical amyloid diseases typically exhibit large amounts of amyloid fibrils (16).”
Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm
Lal, R., Lin, H., & Quist, A. P. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.04.021 · Cited by 205
Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
Salvadores, N., Shahnawaz, M., Scarpini, E., Tagliavini, F., & Soto, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.031 · Cited by 197
“AD belongs to a large group of diseases associated with misfolding, aggregation and tissue accumulation of proteins (Soto, 2003).”
BackgroundSelf-citationUltrasound-mediated piezoelectric differentiation of neuron-like PC12 cells on PVDF membranes
Hoop, M., Chen, X.-Z., Ferrari, A., Mushtaq, F., Ghazaryan, G., Tervoort, T., Poulikakos, D., Nelson, B., & Pané, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-03992-3 · Cited by 199
The Disulfide Isomerase Grp58 Is a Protective Factor against Prion Neurotoxicity
Hetz, C., Russelakis-Carneiro, M., Wälchli, S., Carboni, S., Vial-Knecht, E., Maundrell, K., Castilla, J., & Soto, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4090-04.2005 · Cited by 197
“These findings provide a novel target for transmissible spongiform encephalopathy (TSE) therapy and suggest a general mechanism of neuronal toxicity initiated by the accumulation of misfolded proteins, a common event in several neurodegenerative diseases (Soto, 2003).”
BackgroundSelf-citationNeurodegenerative Disease and the NLRP3 Inflammasome
Holbrook, J. A., Jarosz-Griffiths, H. H., Caseley, E., Lara-Reyna, S., Poulter, J. A., Williams-Gray, C. H., Peckham, D., & McDermott, M. F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643254 · Cited by 194
“This neurodegenerative condition is caused by a CAG-trinucleotide repeat expansion in the huntingtin gene (HTT), that leads to production of defective huntingtin protein, which misfolds and accumulates within neurons, thus forming aggerates that affect normal cellular function (Soto, 2003; Williams and Paulson, 2008).”
BackgroundTraumatic Brain Injury Induces Tau Aggregation and Spreading
Edwards, G., Zhao, J., Dash, P. K., Soto, C., & Moreno-Gonzalez, I. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2018.6348 · Cited by 195
Self-citationGene therapy for neurodegenerative disorders: advances, insights and prospects
Chen, W., Hu, Y., & Ju, D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.015 · Cited by 187
De novo induction of amyloid-β deposition in vivo
Morales, R., Duran-Aniotz, C., Castilla, J., Estrada, L. D., & Soto, C. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.120 · Cited by 191
Self-citationThe Ubiquitin-Proteasome System and the Autophagic-Lysosomal System in Alzheimer Disease
Ihara, Y., Morishima-Kawashima, M., & Nixon, R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006361 · Cited by 190
“In some aging-related neurodegenerative diseases, mutations of the pathogenic gene(s) may also cause anomalous conformations of the encoded protein or its metabolites, leading to increased proteolytic resistance and accumulation of these potentially toxic proteins (Soto 2003).”
BackgroundBourdenx, M., Koulakiotis, N. S., Sanoudou, D., Bezard, E., Dehay, B., & Tsarbopoulos, A. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.003 · Cited by 185
“pathological, one are not completely understood (Soto, 2003).”
Background
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.